TrialThe oncologist2018

Phase II Trial Using a Combination of Oxaliplatin, Capecitabine, and Celecoxib with Concurrent Radiation for Newly Diagnosed Resectable Rectal Cancer.

Emilio P Araujo-Mino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.